Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Sep 16, 2008

Human Stem Cells Injected into Mice Decreased Stroke Damage

  • Researchers at the Center for Gene Therapy at Tulane University discovered that human stem cells derived from bone marrow and injected directly into the brains of mice can reduce the damage caused by a stroke.

    The team found that the stem cells trigger biochemicals from microglia and macrophages that reduce inflammation and protect neurons. They showed that stem cell injection reduced the number of dying or damaged neurons in mice.

    The scientists also investigated how the expression of cerebral genes changed in mice briefly deprived of blood flow to the brain. The authors found that 586 genes were expressed at higher levels after the flow was halted. When stem cells were injected into the brains of the mice, however, 10% fewer genes were upregulated. The reasearchers suggest that those genes are likely involved in inflammatory and immune responses.

    The study appears in PNAS.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »